MED31

mediator complex subunit 31, the group of Mediator complex

Basic information

Region (hg38): 17:6643311-6651634

Links

ENSG00000108590NCBI:51003HGNC:24260Uniprot:Q9Y3C7AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the MED31 gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the MED31 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
0
missense
5
clinvar
5
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
0
Total 0 0 5 0 0

Variants in MED31

This is a list of pathogenic ClinVar variants found in the MED31 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
17-6644523-G-A not specified Uncertain significance (Jan 22, 2024)3125077
17-6644582-G-A not specified Uncertain significance (Nov 17, 2022)2326247
17-6644642-T-C not specified Uncertain significance (Feb 23, 2023)2460975
17-6650072-G-A not specified Uncertain significance (Dec 06, 2021)2265031
17-6651509-A-T not specified Uncertain significance (Aug 14, 2023)2587947
17-6651510-T-G not specified Uncertain significance (Jun 07, 2024)3294074

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
MED31protein_codingprotein_codingENST00000225728 48320
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.0006880.7641256490991257480.000394
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense1.324071.40.5600.00000396859
Missense in Polyphen1026.5720.37634304
Synonymous-0.7383025.31.190.00000125221
Loss of Function0.99369.260.6485.43e-7103

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0005250.000521
Ashkenazi Jewish0.001120.000993
East Asian0.0005690.000544
Finnish0.0002360.000231
European (Non-Finnish)0.0003960.000378
Middle Eastern0.0005690.000544
South Asian0.0005290.000457
Other0.0006690.000652

dbNSFP

Source: dbNSFP

Function
FUNCTION: Component of the Mediator complex, a coactivator involved in the regulated transcription of nearly all RNA polymerase II-dependent genes. Mediator functions as a bridge to convey information from gene-specific regulatory proteins to the basal RNA polymerase II transcription machinery. Mediator is recruited to promoters by direct interactions with regulatory proteins and serves as a scaffold for the assembly of a functional preinitiation complex with RNA polymerase II and the general transcription factors.;
Pathway
Developmental Biology;Gene expression (Transcription);Generic Transcription Pathway;RNA Polymerase II Transcription;Transcriptional regulation of white adipocyte differentiation (Consensus)

Recessive Scores

pRec
0.118

Intolerance Scores

loftool
0.606
rvis_EVS
0.01
rvis_percentile_EVS
54.63

Haploinsufficiency Scores

pHI
0.145
hipred
Y
hipred_score
0.737
ghis
0.618

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
S
essential_gene_gene_trap
E
gene_indispensability_pred
E
gene_indispensability_score
0.801

Mouse Genome Informatics

Gene name
Med31
Phenotype
skeleton phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); limbs/digits/tail phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); embryo phenotype; cellular phenotype; homeostasis/metabolism phenotype; craniofacial phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); growth/size/body region phenotype;

Gene ontology

Biological process
regulation of transcription by RNA polymerase II;transcription initiation from RNA polymerase II promoter;protein ubiquitination;negative regulation of fibroblast proliferation;limb development;positive regulation of nucleic acid-templated transcription
Cellular component
ubiquitin ligase complex;nucleoplasm;mediator complex;core mediator complex
Molecular function
transcription coactivator activity;protein binding;ubiquitin protein ligase activity